SCHEMBL16680288

SCHEMBL16680288

[CH]1CC/C=C/CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1397012 1.00
SCHEMBL147942 1.00
SCHEMBL1112528 1.00
SCHEMBL1112532 1.00
SCHEMBL147941 1.00
SCHEMBL3986701 1.00
SCHEMBL1397014 1.00
SCHEMBL1541739 1.00
SCHEMBL1541066 0.96
SCHEMBL1113741 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207268-A1 PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-06-27 US claimed
EP-4313053-A1 PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) 2024-02-07 EP claimed
CN-114539078-B Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof 南京工业大学 2023-04-07 CN claimed
CN-114539078-A Active small molecular probe for specifically sorting monoamine oxidase, preparation method and application thereof 南京工业大学 2022-05-27 CN claimed
US-20190337939-A1 NANOLUC SUICIDE SUBSTRATES PROMEGA CORPORATION 2019-11-07 US claimed
US-20240207268-A1 PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-06-27 US disclosed
US-20240191211-A1 BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING PROMEGA CORPORATION 2024-06-13 US disclosed
US-20240165259-A1 BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-05-23 US disclosed
US-20240059784-A1 TRANSFERRIN RECEPTOR BINDING PROTEINS AND CONJUGATES ELI LILLY AND COMPANY 2024-02-22 US disclosed
EP-4320073-A1 BIOORTHOGONAL REACTION SUITABLE FOR CLICK/UNCLICK APPLICATIONS Dana-Farber Cancer Institute, Inc. (US) 2024-02-14 EP disclosed
EP-4313053-A1 PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) 2024-02-07 EP disclosed
CN-117337267-A Bioorthogonal reactions suitable for click/click cancellation applications 达纳-法伯癌症研究所公司 2024-01-02 CN disclosed
US-10274490-B2 Magnetic labeling of bacteria THE GENERAL HOSPITAL CORPORATION (US) 2019-04-30 US disclosed
US-10087199-B2 Super-resolution imaging compositions and methods using same YALE UNIVERSITY (US) 2018-10-02 US disclosed
EP-3357903-A1 METHOD AND SYSTEM FOR A CONTINUOUS PRODUCTION OF A Z-CYCLOOCTENE Stichting Katholieke Universiteit (NL) 2018-08-08 EP disclosed
WO-2018045245-A1 CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF SIRENAS LLC (US) 2018-03-08 WO disclosed
WO-2017212329-A1 CLIPTAC COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-12-14 WO disclosed
US-20160223559-A1 TETRAZINE-CONTAINING COMPOUNDS AND SYNTHETIC METHODS THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-08-04 US disclosed
US-20160115180-A1 Novel Super-Resolution Imaging Compositions and Methods Using Same YALE UNIVERSITY 2016-04-28 US disclosed
US-20150125884-A1 Magnetic Labeling of Bacteria THE GENERAL HOSPITAL CORPORATION 2015-05-07 US disclosed